26°C
30°C
26.6°C
Journal
- The New England Journal of Medicine (NEJM). Coronavirus (Covid-19)
- JAMA. Coronavirus Disease 2019 (COVID-19)
- BMJ's Coronavirus (covid-19) Hub
- BMJ Best Practice. Coronavirus Disease 2019 (COVID-19)
- Science. Coronavirus
- British Society for Antimicrobial Chemotherapy. COVID-19: Resource Hub
- National Institutes of Health. LitCovid
- Cochrane Library. Coronavirus (COVID-19)
- Cochrane [Special Collection: Coronavirus (COVID-19): Evidence Relevant to Critical Care]
- Annals of Internal Medicine. COVID-19 Article Collection and Resources
- Infectious Diseases Society of America (IDSA). COVID-19 Information and Safety Resources
- Elsevier COVID-19 Healthcare Hub
- Imperial College London. COVID-19 report
- Hong Kong Medical Journal. Coronavirus Disease 2019 (COVID-19)
- COVID-END - COVID-19 Evidence Network to support Decision-making
► Post COVID-19 Condition (Long COVID)
- The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies (May 07, 2025)
- Sex Differences in Long COVID (January 22, 2025)
- 2024 Update of the RECOVER-Adult Long COVID Research Index (December 18, 2024)
- Interventions for the management of long covid (post-covid condition): living systematic review (November 27, 2024)
- Characterizing Long COVID in Children and Adolescents (August 21, 2024)
- Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis (March 2024)
- Muscle abnormalities worsen after post-exertional malaise in long COVID (January 04, 2024)
- Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study (May 31, 2023)
- Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis (March 23, 2023)
- Long COVID after breakthrough SARS-CoV-2 infection (May 25, 2022)
- Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study (October 2021)
- Long covid—mechanisms, risk factors, and management (July 26, 2021)
- Attributes and predictors of long COVID (March 10, 2021)
- Antibody tests for identification of current and past infection with SARS‐CoV‐2 (November 17, 2022)
- Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests (June 28, 2022)
- Rapid, point‐of‐care antigen tests for diagnosis of SARS-CoV-2 infection (July 22, 2022)
- Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? (October 2021)
- Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis (September 2021)
- COVID-19: Evaluation and management of adults with acute infection in the outpatient setting (last updated: June 12, 2025)
- In-hospital outcomes and 6-month follow-up results of patients supported with extracorporeal membrane oxygenation for COVID-19 from the second wave to the end of the pandemic (EuroECMO-COVID): a prospective, international, multicentre, observational study (February 23, 2025
- Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron (February 05, 2025)
- COVID-19 responses in vulnerable populations: from clinical management to healthcare policies (December 2024)
- Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras (July 17, 2024)
- Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19 (July 17, 2024)
- Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 (April 03, 2024)
- Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19 (November 30, 2023)
- Early versus late tracheostomy in critically ill COVID-19 patients (November 20, 2023)
- A living WHO guideline on drugs for covid-19 (September 04, 2020, last updated: November 10, 2023)
- Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study (August 09, 2023)
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 (February 16, 2022)
- Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019 (January 15, 2022)
- The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study (December 2021)
- Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study (December 01, 2021)
- Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study (August 14, 2021)
- 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study (July 2021)
- Post-acute COVID-19 syndrome (March 22, 2021)
- De-isolating COVID-19 Suspect Cases: A Continuing Challenge (August 01, 2020)
- Dexamethasone in Hospitalized Patients with Covid-19 (July 17, 2020)
- Dexamethasone in Hospitalized Patients with Covid-19—Preliminary Report (July 17, 2020)
- Extrapulmonary manifestations of COVID-19 (July 10, 2020)
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial (May 16, 2020)
- COVID-19: Immunopathology and its implications for therapy (April 09, 2020)
- COVID-19: Consider cytokine storm syndromes and immunosuppression (March 28, 2020)
- Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series (February 19, 2020)
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome (February 18, 2020)
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster (February 15, 2020)
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (February 15, 2020)
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (February 15, 2020)
- Novel coronavirus infection in hospitalized infants under 1 year of age in China (February 14, 2020)
- Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia (February 13, 2020)
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province (February 07, 2020)
- Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020 (2020)
► Risk Factors for Severity and Prognostic Indicators
- Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023 (February 15, 2024)
- Obesity as an independent risk factor for COVID-19 severity and mortality (May 24, 2023)
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality (January 19, 2022)
- Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections (December 2021)
- A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19 (November 2020)
- Risk factors for severe and critically ill COVID-19 patients: A review (November 13, 2020)
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study (October 2020)
- Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US (July 15, 2020)
- Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy (July 15, 2020)
- Increased risk of COVID-19 among users of proton pump inhibitors (October 2020)
- Clinical features of fatalities in patients with COVID-19. Disaster Medicine and Public Health Preparedness (July 15, 2020)
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (March 28, 2020)
- COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years (February 24, 2025)
- Efficacy and safety of COVID-19 vaccines (December 7, 2022)
- Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review (November 2022)
- Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review (August 09, 2022)
- Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study (January 2022)
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study (October 16, 2021)
- Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study (September 25, 2021)
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings (September 08, 2021)
- Impact of the influenza vaccine on COVID-19 infection rates and severity (June 2021)
- An mRNA Vaccine against SARS-CoV-2 - Preliminary Report (July 14, 2020)
- Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults (March 31, 2022)
- Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 – June 2021 (October 09, 2021)
- Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19 (April 22, 2021)
- SARS-CoV-2 Antibody Response in Persons with Past Natural Infection (April 14, 2021)
- Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear (July 03, 2020)
- SARS-CoV-2 viral load in upper respiratory specimens of infected patients (February 19, 2020)
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding (January 30, 2020)
- Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event (January 29, 2020)
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan (January 28, 2020)
- A novel coronavirus from patients with pneumonia in China, 2019 (January 24, 2020)
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (January 23, 2020)
► Epidemiology and Infection Control
- COVID-19 infection control practices in designated quarantine hotels in Hong Kong SAR (China), 2020–2022: key elements in preparing for the next pandemic (March 04, 2025)
- Summary of WHO infection prevention and control guideline for covid-19: striving for evidence based practice in infection prevention and control (May 23, 2024)
- Lessons from the COVID-19 pandemic for ventilation and indoor air quality (July 25, 2024)
- Impact of infection prevention and control practices, including personal protective equipment, on the prevalence of hospital-acquired infections in acute care hospitals during COVID-19: a systematic review and meta-analysis (Feburay 27, 2024)
- Not only COVID-19: a systematic review of anti-COVID-19 measures and their effect on healthcare-associated infections (Febuary 27, 2024)
- COVID-END inventory Evidence about public-health measures (January 2024)
- Effects of public-health measures for zeroing out different SARS-CoV-2 variants (August 29, 2023)
- Communication to support physical distancing for COVID-19 prevention and control (October 09, 2023)
- Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings (May 06, 2022)
- Measures implemented in the school setting to contain the COVID-19 pandemic (January 17, 2022)
- Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review (September 15, 2021)
- Joint Estimation of Generation Time and Incubation Period for Coronavirus Disease 2019 (August 23, 2021)
- Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19 (April 05, 2021)
- Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review (December 17, 2020)
- It is time to address airborne transmission of covid-19 (July 06, 2020)
- Serial Interval of COVID-19 among Publicly Reported Confirmed Cases (June 2020)
- Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff (May 15, 2020)
- Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review (April 28, 2020)
- Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak (March 30, 2020)
- Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19 (March 26, 2020)
- Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship (March 06, 2020)
- Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient (March 04, 2020)
- Protecting health-care workers from subclinical coronavirus infection (March 1, 2020)
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study (February 29, 2020)
- Key Points of the Program for Disinfection Technology in Special Places During the Coronavirus Disease-2019 (COVID-19) Outbreak (February 28, 2020)
- Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China (February 27, 2020)
- Importation and human-to-human transmission of a novel coronavirus in Vietnam (February 27, 2020)
- Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents (Febuary 06, 2020)
- Transmission of 2019-nCoV infection from an asymptomatic contact in Germany (January 30, 2020)
- Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia (January 29, 2020)
- Presumed asymptomatic carrier transmission of COVID-19 (February 21, 2020)
- Investigation of a Cluster of 2019 Novel Coronavirus Disease (COVID-19) with Possible Transmission During the Incubation Period — Shenyang City, China, 2020 (February 21, 2020)
- Asymptomatic cases in a family cluster with SARS-CoV-2 infection (February 19, 2020)
- Coronavirus Disease 2019 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients (February 05, 2025)
- Association Between SARS-CoV-2 Infection During Pregnancy and Gestational Diabetes: A Claims-based Cohort Study (August 19, 2024)
- Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study (July 17, 2024)
- Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis (July 15, 2024)
- Neonatal Outcomes After COVID-19 Vaccination in Pregnancy (February 06, 2024)
- Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study (January 24, 2024)
- Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants (June 22, 2022)
- Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy (June 22, 2022)
- Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy (May 10, 2022)
- Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection (October 2021)
- SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women (April 12, 2021)
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis (September 01, 2020)
- Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis (July 12, 2020)
- A systematic scoping review of COVID‐19 during pregnancy and childbirth (April 24, 2020)
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records (February 12, 2020)
► Disinfection and Environmental Stability
- A review on sterilization methods of environmental decontamination to prevent the coronavirus SARS-CoV-2 (COVID-19 virus): A new challenge towards eco-friendly solutions (August 04, 2023)
- Disinfection methods against SARS-CoV-2: a systematic review (October 18, 2022)
- Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 (September 29, 2022)
- Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis (November 18, 2021)
- Role of the Healthcare Surface Environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Potential Control Measures (September 28, 2020)
- Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses (June 24, 2020)
- Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight (June 11, 2020)
- Stability of SARS-CoV-2 in different environmental conditions (April 02, 2020)
- Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 (March 17, 2020)
- Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals: Retrospective Cohort Study of Trends and Risk Factors (April 29, 2025)
- Antimicrobial Resistance Threats in the United States, 2021-2022 (April 11, 2025)
- Azithromycin Resistance Patterns in Escherichia coli and Shigella before and after COVID-19, Kenya (October 2024)
- Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data (May 14, 2024)
- How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship? (June 05, 2023)
- Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis (Junuary 31, 2023)
- Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis (December 09, 2022)
- The overlooked pandemic of antimicrobial resistance (Junuary 19, 2022)
- COVID-19 drug practices risk antimicrobial resistance evolution (February 24, 2021)
- Antimicrobial resistance and COVID-19: Intersections and implications (February 16, 2021)
- PRO: the COVID-19 pandemic will result in increased antimicrobial resistance rates (July 17, 2020)
- CON: COVID-19 will not result in increased antimicrobial resistance prevalence (July 17, 2020)
- Tackling antimicrobial resistance in the COVID-19 pandemic (July 01, 2020)
- Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies (June 16, 2020)
- How covid-19 is accelerating the threat of antimicrobial resistance (May 18, 2020)
- Impact of COVID-19 on traditional healthcare-associated infection prevention efforts (April 16, 2020)
Top